650
Participants
Start Date
October 20, 2015
Primary Completion Date
May 8, 2017
Study Completion Date
November 10, 2017
Saxagliptin, Onglyza
Tablets, Oral, 5mg , Once daily, 24 weeks
Dapagliflozin, Farxiga
Tablets, Oral, 10mg , Once daily, 24 weeks
Glargine insulin
100 Units/ml solution for injection in a prefilled SoloStar pen
Metformin
Tablets, Oral, ≥ 1500mg/≤ 2500mg, Once daily, 24 weeks
Research Site, Budapest
Research Site, Budapest
Research Site, Budapest
Research Site, Lenasia
Research Site, Copenhagen
Research Site, A Coruña
Research Site, Barto
Research Site, Columbia
Research Site, Norcross
Research Site, Miami
Research Site, Miami
Research Site, St. Petersburg
Research Site, Bristol
Research Site, Kingsport
Research Site, Lexington
Research Site, Guadalajara
Research Site, Zapopan, Jalisco
Research Site, Beavercreek
Research Site, Chicago
Research Site, Monterrey
Research Site, Norman
Research Site, Mesquite
Research Site, Houston
Research Site, San Antonio
Research Site, San Antonio
Research Site, Bountiful
Research Site, Los Angeles
Research Site, Anaheim
Research Site, Ploieşti
Research Site, Craiova
Research Site, Timișoara
Research Site, Timișoara
Research Site, Quincy
Research Site, Karlovy Vary
Research Site, Olomouc
Research Site, México
Research Site, Lodz
Research Site, Nowy Duninów
Research Site, Sochaczew
Research Site, Uddevalla
Lead Sponsor
AstraZeneca
INDUSTRY